clinical outcomes are similar when deficiencies are correctedchoose based on availability, tolerance, and clinician preference
A peptide that modulates VEGFR2 in a cell culture dish, or heals a rat tendon at 10 mcg/kg IP injection, has not been shown to survive oral delivery in a human at 500 mcg and reach musculoskeletal tissue at any meaningful concentration
No data exists on developmental effects, and cell proliferating properties raise theoretical concerns
As of 2024, there are small studies to suggest that topical or oral formulations of glutathione can help reduce melasma severity
Stage-Specific changes in the water, Na+, Cl- and K+ contents of organelles during apoptosis, demonstrated by a targeted cryo correlative analytical approach